These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo. de Bruyn M; Rybczynska AA; Wei Y; Schwenkert M; Fey GH; Dierckx RA; van Waarde A; Helfrich W; Bremer E Mol Cancer; 2010 Nov; 9():301. PubMed ID: 21092273 [TBL] [Abstract][Full Text] [Related]
5. Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance. Campoli MR; Chang CC; Kageshita T; Wang X; McCarthy JB; Ferrone S Crit Rev Immunol; 2004; 24(4):267-96. PubMed ID: 15588226 [TBL] [Abstract][Full Text] [Related]
6. Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen. Faassen AE; Mooradian DL; Tranquillo RT; Dickinson RB; Letourneau PC; Oegema TR; McCarthy JB J Cell Sci; 1993 Jun; 105 ( Pt 2)():501-11. PubMed ID: 7691842 [TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Pluschke G; Vanek M; Evans A; Dittmar T; Schmid P; Itin P; Filardo EJ; Reisfeld RA Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9710-5. PubMed ID: 8790396 [TBL] [Abstract][Full Text] [Related]
8. Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen. Iida J; Pei D; Kang T; Simpson MA; Herlyn M; Furcht LT; McCarthy JB J Biol Chem; 2001 Jun; 276(22):18786-94. PubMed ID: 11278606 [TBL] [Abstract][Full Text] [Related]
9. Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers. Abnormal expression in merosin-negative and Duchenne muscular dystrophies. Petrini S; Tessa A; Carrozzo R; Verardo M; Pierini R; Rizza T; Bertini E Mol Cell Neurosci; 2003 Jun; 23(2):219-31. PubMed ID: 12812755 [TBL] [Abstract][Full Text] [Related]
10. Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). Iida J; Wilhelmson KL; Ng J; Lee P; Morrison C; Tam E; Overall CM; McCarthy JB Biochem J; 2007 May; 403(3):553-63. PubMed ID: 17217338 [TBL] [Abstract][Full Text] [Related]
11. Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain. Yang J; Price MA; Wanshura LEC; He J; Yi M; Welch DR; Li G; Conner S; Sachs J; Turley EA; McCarthy JB Melanoma Res; 2019 Aug; 29(4):365-375. PubMed ID: 31140988 [TBL] [Abstract][Full Text] [Related]
12. Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis. Legg J; Jensen UB; Broad S; Leigh I; Watt FM Development; 2003 Dec; 130(24):6049-63. PubMed ID: 14573520 [TBL] [Abstract][Full Text] [Related]
13. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. Faassen AE; Schrager JA; Klein DJ; Oegema TR; Couchman JR; McCarthy JB J Cell Biol; 1992 Jan; 116(2):521-31. PubMed ID: 1730766 [TBL] [Abstract][Full Text] [Related]
14. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740 [TBL] [Abstract][Full Text] [Related]
15. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway. Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433 [TBL] [Abstract][Full Text] [Related]
16. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma. Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024 [TBL] [Abstract][Full Text] [Related]
17. Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patients. Erfurt C; Müller E; Emmerling S; Klotz C; Hertl M; Schuler G; Schultz ES Int J Cancer; 2009 May; 124(10):2341-6. PubMed ID: 19173283 [TBL] [Abstract][Full Text] [Related]
18. High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis. Xu T; Ma M; Chi Z; Si L; Sheng X; Cui C; Dai J; Yu S; Yan J; Yu H; Wu X; Tang H; Yu J; Kong Y; Guo J Cancer Sci; 2018 Jun; 109(6):1787-1798. PubMed ID: 29660787 [TBL] [Abstract][Full Text] [Related]
19. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling. Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247 [TBL] [Abstract][Full Text] [Related]
20. Expression of MCSP and PRAME in conjunctival melanoma. Westekemper H; Karimi S; Süsskind D; Anastassiou G; Freistühler M; Meller D; Zeschnigk M; Steuhl KP; Bornfeld N; Schmid KW; Grabellus F Br J Ophthalmol; 2010 Oct; 94(10):1322-7. PubMed ID: 20805128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]